NCT05944380

PENG Block for Total Hip Arthroplasty

Periarticular Nerve Group (PENG) Block for Postoperative Rehabilitation in Total Hip Arthroplasty: a Randomized Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 556 (actual)
• Sponsor: Poznan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the pericapsular nerve group block on postoperative rehabilitation.

Detailed description

The pericapsular nerve group, or PENG block, has been recently described and shows promise in providing analgesia to the hip joint. However, the effect of this block on postoperative rehabilitation is uncertain. This study compares a preoperative PENG block to a placebo before total hip arthroplasty under spinal anesthesia. The primary outcome measure is verticalization, walking distance, ability to go out of bed, active lifting of the limb, range of motion in the hip joint, bending range of motion, and abduction range of motion. The secondary measure is postoperative pain assessment during rehabilitation.

Conditions

• Hip Osteoarthritis
• Hip Arthropathy
• Hip Disease
• Hip Pain Chronic

Interventions

Type	Name	Description
DRUG	Ropivacaine 0.5% Injectable Solution	20 mL 0.5% ropivacaine will be injected for the PENG block
DRUG	0,9% normal saline	20 mL 0.9% normal saline will be injected for the PENG block

Timeline

• Start date: 2020-06-16
• Primary completion: 2022-06-23
• Completion: 2023-01-30
• First posted: 2023-07-13
• Last updated: 2023-07-13

Locations

1 site across 1 country: Poland